ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight

ClinicalTrials.gov ID: NCT05929079

Public ClinicalTrials.gov record NCT05929079. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 9:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight: A Randomized Double-Blind, Placebo-Controlled Trial

Study identification

NCT ID
NCT05929079
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,000 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Retatrutide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 10, 2023
Primary completion
Apr 30, 2026
Completion
Apr 30, 2026
Last update posted
Apr 12, 2026

2023 – 2026

United States locations

U.S. sites
40
U.S. states
20
U.S. cities
39
Facility City State ZIP Site status
Pinnacle Research Group, LLC Anniston Alabama 36207
Cullman Clinical Trials Cullman Alabama 35055
Preferred Research Partners Little Rock Arkansas 72211
Core Healthcare Group Cerritos California 90703
Velocity Clinical Research, Westlake Los Angeles California 90057
Valley Clinical Trials, Inc. Northridge California 91325
Diablo Clinical Research, Inc. Walnut Creek California 94598
Chase Medical Research, LLC Waterbury Connecticut 06708
Excel Medical Clinical Trials Boca Raton Florida 33434
Teradan Clinical Trials, LLC Brandon Florida 33511
Fleming Island Center for Clinical Research Fleming Island Florida 32003
Therafirst Medical Center Fort Lauderdale Florida 33308
Clinical Site Partners LLC, dba Flourish Research Miami Florida 33186
Quantum Clinical Trials Miami Beach Florida 33140
Renstar Medical Research Ocala Florida 34470
Clinical Research Center of Florida Pompano Beach Florida 33060
Palm Beach Research Center West Palm Beach Florida 33409
Clinical Site Partners, LLC dba Flourish Research Winter Park Florida 32789
NeuroTrials Research Inc Atlanta Georgia 30328
Centricity Research Rincon Pulmonology Rincon Georgia 31406
East-West Medical Research Institute Honolulu Hawaii 96814
Brengle Family Medicine Indianapolis Indiana 46260
MedVadis Research Corporation Waltham Massachusetts 02451
StudyMetrix Research City of Saint Peters Missouri 63303
Las Vegas Medical Research Las Vegas Nevada 89128
Mid Hudson Medical Research New Windsor New York 12553
Monroe Biomedical Research Monroe North Carolina 28112
Carteret Medical Group Morehead City North Carolina 28557
Lillestol Research Fargo North Dakota 58104
CTI Clinical Research Center Cincinnati Ohio 45212
Intrepid Research Cincinnati Ohio 45245
Preferred Primary Care Physicians, Preferred Clinical Research (Ofc 18) Pittsburgh Pennsylvania 15236
Preferred Primary Care Physicians Uniontown Pennsylvania 15401
Tribe Clinical Research, LLC Greenville South Carolina 29607
Trial Management Associates Myrtle Beach South Carolina 29572
Tribe Clinical Research - Spartanburg Spartanburg South Carolina 29301
FutureSearch Trials of Neurology Austin Texas 78731
Velocity Clinical Research, Dallas Dallas Texas 75230
Advanced Research Institute Ogden Utah 84405
Northwest Clinical Research Center Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05929079, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 12, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05929079 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →